Last reviewed · How we verify

Rocroniom, Non Depolarizing Muscle Relaxant

Muhammad Magdy Gaber · Phase 1 active Small molecule Quality 3/100

Rocroniom, Non Depolarizing Muscle Relaxant is a Small molecule drug developed by Muhammad Magdy Gaber. It is currently in Phase 1 development. Also known as: Nerve stimulator for train of four assessment, BIS bispectral index.

At a glance

Generic nameRocroniom, Non Depolarizing Muscle Relaxant
Also known asNerve stimulator for train of four assessment, BIS bispectral index
SponsorMuhammad Magdy Gaber
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Rocroniom, Non Depolarizing Muscle Relaxant

What is Rocroniom, Non Depolarizing Muscle Relaxant?

Rocroniom, Non Depolarizing Muscle Relaxant is a Small molecule drug developed by Muhammad Magdy Gaber.

Who makes Rocroniom, Non Depolarizing Muscle Relaxant?

Rocroniom, Non Depolarizing Muscle Relaxant is developed by Muhammad Magdy Gaber (see full Muhammad Magdy Gaber pipeline at /company/muhammad-magdy-gaber).

Is Rocroniom, Non Depolarizing Muscle Relaxant also known as anything else?

Rocroniom, Non Depolarizing Muscle Relaxant is also known as Nerve stimulator for train of four assessment, BIS bispectral index.

What development phase is Rocroniom, Non Depolarizing Muscle Relaxant in?

Rocroniom, Non Depolarizing Muscle Relaxant is in Phase 1.

Related